Intellia Therapeutics Inc buy William Blair
Start price
25.03.23
/
50%
€35.09
Target price
25.03.24
-
Performance (%)
-29.81%
End price
26.03.24
€24.63
Summary
This prediction ended on 26.03.24 with a price of €24.63. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.81%. William_Blair has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. William_Blair has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | 7.993% | 7.993% | 89.044% | -66.789% |
| iShares Core DAX® | -0.676% | 4.053% | 2.212% | 52.786% |
| iShares Nasdaq 100 | 0.993% | 10.872% | 38.041% | 94.873% |
| iShares Nikkei 225® | 3.279% | 13.468% | 59.003% | 70.295% |
| iShares S&P 500 | 0.621% | 6.195% | 26.154% | 68.910% |
Comments by William_Blair for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von William_Blair gewählte maximale Laufzeit wurde überschritten
Current prediction by William_Blair for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.98
02.03.26
02.03.26
-
02.03.27
02.03.27
-9.55%
22:25
22:25
